Enhancing cancer immunotherapies by targeting specific immune cells

Targeting lymphoid tissue residency to boost tumor immunotherapies

NIH-funded research South Texas Veterans Health Care System · NIH-10950299

This study is looking at how special immune cells can be used more effectively to make cancer treatments, like certain vaccines and therapies, work better for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSouth Texas Veterans Health Care System NIH-funded
Lab location1 site (San Antonio, United States)
Project IDNIH-10950299 on NIH RePORTER

What this research studies

This research investigates how certain immune cells, specifically stem-like tumor-specific CD8+ T cells, can be better utilized to improve cancer immunotherapies such as PD-1/PD-L1 blockade and tumor vaccines. The study focuses on understanding the mechanisms that allow these cells to reside in lymphoid tissues and how they can be activated to enhance anti-tumor responses. By exploring the role of tissue-resident memory T cells and their interactions with tumor environments, the research aims to identify new strategies to boost the effectiveness of existing cancer treatments.

Who could benefit from this research

Good fit: Ideal candidates for this research are cancer patients who are undergoing or considering immunotherapy treatments.

Not a fit: Patients with non-cancerous conditions or those not receiving immunotherapy may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer immunotherapies, improving survival rates and quality of life for cancer patients.

How similar studies have performed: Previous research has shown promising results in enhancing cancer immunotherapies by targeting specific immune cell populations, indicating potential for success in this approach.

Where this research is happening

San Antonio, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions acute infection
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.